FdaApplication
ANDA 202285
Identifiers
- fda_app_no: ANDA202285
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2014-05-12 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OLANZAPINE | OLANZAPINE | 20MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| OLANZAPINE | OLANZAPINE | 10MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| OLANZAPINE | OLANZAPINE | 5MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| OLANZAPINE | OLANZAPINE | 15MG | TABLET, ORALLY DISINTEGRATING;ORAL |
4 products